Our results show that iPSC-CM are useful for investigating the similarities/differences in the pathophysiological consequences of RyR2 versus CASQ2 mutations underlying CPVT1 and CPVT2 syndromes. This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia 1.